Página 2 - Melhores Glioma médicos - TOP-66 médicos

Neurocirurgião de renome mundial, o Prof. Zvi Ram lidera a Associação Europeia de Sociedades de Neurocirurgia e oferece cuidados inovadores para gliomas no Sourasky Medical Center.

• Especialista em cirurgia complexa de tumores cerebrais com mapeamento cerebral e estimulação cerebral profunda
• Altamente qualificado em técnicas microcirúrgicas e guiadas por imagem para tumores cerebrais
• Conduz pesquisas de ponta em terapias genéticas para câncer cerebral
• Reconhecido com o Goldhirsh Foundation Award por tratamentos neurológicos inovadores

O Dr. Yildiz possui mais de uma década de experiência especializada em oncologia, com foco em casos avançados de cancro no Hospital Universitário Medipol Mega.

• Mais de 15 anos de experiência em oncologia médica
• Deter uma cátedra em oncologia – um especialista que forma outros médicos
• Publicar extensivamente em revistas médicas internacionais sobre vários tipos de cancro
• Membro da Sociedade Europeia de Oncologia Médica (ESMO)
• Interesse especial em tumores neuroendócrinos e gestão de casos complexos

O Prof. Dr. Wolfgang Köstler é um especialista de renome no tratamento de gliomas, especializado em terapias-alvo e medicina oncológica personalizada na Wiener Privatklinik.

• Mais de 20 anos de experiência em oncologia médica
• Foco no desenvolvimento de biomarcadores e biologia tumoral
• Subchefe da Divisão Clínica de Oncologia da Universidade Médica de Viena
• Autor de publicações extensas em importantes periódicos internacionais

O Professor Keil é especialista em técnicas avançadas de imagem para glioma, com especialização em radiologia diagnóstica e intervencionista no Hospital Académico de Solingen.

• Graduado com honras pela Universidade Julius-Maximilian de Würzburg
• Mais de 16 anos de experiência em radiologia, incluindo diagnóstico por RM e TC
• Antigo médico-chefe do Hospital Universitário de Aachen
• Especializado em imagiologia de secção transversal para intervenções médicas complexas

A Dra. Viola Fox chefia a Clínica de Hematologia, Oncologia e Cuidados Paliativos do BKZ Solingen, com mais de 15 anos de experiência especializada no tratamento de gliomas e outros tumores.

• Especializar-se em quimioterapia, imunoterapia e terapias direcionadas
• Qualificar-se em genética para aprimorar abordagens de tratamento personalizado
• Atuar na pesquisa em biologia molecular para terapias oncológicas inovadoras
• Ser membro de sociedades de oncologia alemãs e americanas

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

O Prof. Adjunto Nail Paksoy é um oncologista médico especializado no tratamento de gliomas no Hospital Medipol Bahçelievler, com certificação pela ESMO e vasta experiência em investigação.

• Formação especializada no Instituto de Oncologia da Universidade de Istambul
• Participação em 8 ensaios clínicos internacionais para tratamentos de cancro
• Publicação de múltiplos estudos sobre tumores cerebrais e neuro-oncologia
• Certificado pela ESMO em Oncologia Médica

Especialista em viroterapia – um dos campos mais recentes da imunologia – com mais de 30 anos de experiência na Clínica Pallas.

• Chefe do Centro de Imunologia Clínica do Hospital Universitário Clínico Pauls Stradins
• Graduado pelo Instituto Médico de Riga
• Internato em Medicina Interna

O Dr. Alemdar é especialista em Oncologia Médica com formação extensiva na Universidade Akdeniz – líder em cuidados oncológicos.

• Certificado em Oncologia Médica desde 2018
• Mais de 15 anos de experiência em oncologia
• Trabalhar no Complexo Hospitalar Medical Park Antalya

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Pioneiro na definição de critérios rigorosos para as síndromes neurológicas paraneoplásicas – o Dr. Graus é uma figura proeminente em neuro-oncologia no Hospital Quiron Barcelona.

• Antigo Chefe de Neurologia no Hospital Clinic, Barcelona
• Fundador e ex-presidente da Associação Europeia de Neuro-Oncologia
• Formado em neuro-oncologia no Memorial Sloan-Kettering Cancer Center
• Homenageado com o título de Doutor Honoris Causa pela Universidade de Lyon

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.